Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 887 results found. Search for [ USFDA ]

Results 1 to 21 of 887
BusinessToday.In
December 16, 2019
Share Market : Key benchmark indices Sensex and Nifty turned volatile and ended lower on Monday, tracking global equities


E Kumar Sharma
New Delhi, December 10, 2019
Diabetes drug price: Companies are talking of a significant price cut. Intas Pharmaceuticals, according to a senior official in the company, will hit the market today with two versions


E Kumar Sharma
December 2, 2019
Earlier this month, AstraZeneca announced three large-scale initiatives to build on the company's long-standing commitment to China and advance global R&D for innovative new medicines


PTI
November 26, 2019
Glenmark's current portfolio consists of 164 products authorised for distribution in the US marketplace and 44 abbreviated new drug applications pending approval with the USFDA


E Kumar Sharma
New Delhi, November 25, 2019
A number of biologics with huge markets are going off-patent in the US. Do Indian pharmaceutical companies have it in them to play this high-cost, high-risk game of launching biosimilars?


BusinessToday.In
November 25, 2019
Snapping three-days losing streak, the share price of Unichem Laboratories opened higher, rising 7.4% to touch the day's high of Rs 164 apiece on the BSE


PTI
New Delhi, November 24, 2019
Aurobindo Pharma's net debt decreased by $71 million quarter-on-quarter to $522 million at the end of September 2019


BusinessToday.In
November 21, 2019
Cadila Healthcare share price has lost 29% in one year and fallen 27% since the beginning of this year


Dipak Mondal
New Delhi, November 19, 2019
The Company Law committee constituted by the ministry of corporate affairs in September this year has also recommended amending 46 penal provisions under the Companies Act to either remove criminality or to restrict the punishment to only fine in case of certain defaults committed by companies


PTI
November 18, 2019
The significant violations included failure to have adequate written procedures for the receipt, identification, testing and handling of raw materials


PTI
November 18, 2019
Prasad said there was a need for the government to focus on and invest more in primary healthcare


PB Jayakumar
November 6, 2019
Most violations relate to rectifiable documentation, data maintenance, batch-wise consistent production quality, data on supply chain, stability issues, microbial contamination and quality checks


BusinessToday.In
New Delhi, November 4, 2019
SPARC Q2 results: Total income declined sharply by 70.49 per cent to Rs 19.45 crore during the second quarter as compared with Rs 65.92 crore in the year-ago period


BusinessToday.In
November 4, 2019
The USFDA warning letter will not affect the existing business of Cadila Healthcare in the US and the existing product supplies from the Moraiya facility will continue


BusinessToday.In
November 4, 2019
Cadila Healthcare share which opened at Rs 257 against previous close of Rs 255.30 hit an intra day high of Rs 260.6 (2.08%)


BusinessToday.In
November 4, 2019
HDFC Q2 results: The total revenue from operations increased by 10.35 per cent to Rs 10,478.33 crore in Q2FY20 from Rs 9,494.70 crore in Q2FY19


E Kumar Sharma
New Delhi, November 2, 2019
Dr Reddy's CFO Saumen Chakraborty attributed much of the challenges in the US market to price erosion and lower volumes


PTI
New Delhi, October 13, 2019
Torrent Pharma recalls drugs from US, Puerto Rico: As per the report, Torrent Pharma Inc is recalling 17,088 bottles of Losartan Potassium /Hydrochlorothiazide tablets, USP 50mg/12.5mg from the same markets.


BusinessToday.In
October 11, 2019
Cipla share price has lost 2.51% in last 2 days. The US drug regulator carried out inspection from September 16-September 27 in the Goa unit of the firm.  It has subsequently issued form 483 comprising 38 pages which carries 12 observations for the Cipla's Goa facility.


BusinessToday.In
October 10, 2019
The Tata Motors Group global wholesales in September 2019, including Jaguar Land Rover, were at 89,912 units, lower by 27%, as compared to September 2018.


PAGES 1 OF 45  12345